![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.574, 2009-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Darifenacin improves HRQOL in patients with OAB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cetuximab extends survival in patients with mCRC
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Levetiracetam improves HRQOL in epilepsy . . .
Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Levocetirizine improves HRQOL in children with PAR
Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Levocetirizine improves HRQOL in children with PAR
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :